Now position:HomeTECHNOLOGIES



Transferring the Future of Cell Industry|VNK

Transferring the Future of Cell Industry|New Product Launch – VNK

The most well-known types of cell therapy are as follows:
1. NK cell (Natural Killer Cell) for cancer treatment.
2. T cell for enhancing immune system.
3. Stem cell for severe disease treatment.

Although they cure specific diseases with specific functions.


In view of this, ReBlood Group has integrated the above-mentioned NK, T and stem cell products into a trio,the original products have been combined into a new product – VNK.

VNK reduces the incidence of critical illness. It also be used in daily care to keep the body functioning properly.

With this new product, we believe it will bring about significant positive benefits to human health and is expected to be a major innovation in transferring cell industry.